Axogen (AXGN) Cash & Current Investments (2010 - 2026)

Axogen's (AXGN) quarterly Cash & Current Investments came in at $101.6 million in Q1 2026, up 360.38% year-on-year from $22.1 million in Q1 2025, and up 144.66% quarter-over-quarter from $41.5 million in Q4 2025.

Axogen (AXGN) Cash & Current Investments (2010 - 2026) Analysis & Trends

Axogen's Cash & Current Investments history runs 17 years deep, the most recent figure standing at $101.6 million for Q1 2026.

  • On a quarterly basis, Cash & Current Investments rose 360.38% year-over-year to $101.6 million in Q1 2026; TTM through Mar 2026 was $101.6 million, a 360.38% increase from a year earlier, with the FY2025 full-year figure at $41.5 million, up 24.03% from the prior year.
  • Cash & Current Investments grew to $101.6 million in Q1 2026 per AXGN's latest filing, from $41.5 million in the prior quarter.
  • Across five years, Cash & Current Investments topped out at $101.6 million in Q1 2026 and bottomed at $17.6 million in Q1 2024.
  • The 5-year median for Cash & Current Investments is $34.5 million (2023), against an average of $40.6 million.
  • Across the five-year window, Cash & Current Investments slumped 53.43% in 2024 and jumped 360.38% in 2026, its largest moves.
  • Year by year, Cash & Current Investments stood at $48.8 million in 2022, then tumbled by 36.41% to $31.0 million in 2023, then gained by 7.92% to $33.5 million in 2024, then grew by 24.03% to $41.5 million in 2025, then soared by 144.66% to $101.6 million in 2026.
  • Per Business Quant, the three latest AXGN Cash & Current Investments figures stand at $101.6 million (Q1 2026), $41.5 million (Q4 2025), and $35.8 million (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Current Investments (Qtr)
1 Abbott Laboratories 182.32 Bn 175.02 Bn 6.27 Bn 7.30 Bn
2 Stryker 128.75 Bn 125.88 Bn 3.81 Bn 2.88 Bn
3 Medtronic 107.83 Bn 98.61 Bn 6.41 Bn 9.22 Bn
4 Boston Scientific 67.61 Bn 66.15 Bn 3.61 Bn 1.45 Bn
5 Edwards Lifesciences 48.13 Bn 44.45 Bn 1.29 Bn 3.67 Bn
6 Dexcom 28.26 Bn 27.14 Bn 750.30 Mn 1.12 Bn
7 GE HealthCare Technologies 27.78 Bn 25.50 Bn 1.98 Bn 2.29 Bn
8 Smith & Nephew 26.99 Bn 26.41 Bn - 577.00 Mn
9 Koninklijke Philips 23.92 Bn 20.80 Bn 2.07 Bn 3.12 Bn
10 Axogen 2.12 Bn 2.02 Bn 46.19 Mn 101.60 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 101.60 Mn
Dec 31, 2025 41.53 Mn
Sep 30, 2025 35.79 Mn
Jun 30, 2025 29.92 Mn
Mar 31, 2025 22.07 Mn
Dec 31, 2024 33.48 Mn
Sep 30, 2024 24.53 Mn
Jun 30, 2024 21.13 Mn
Mar 31, 2024 17.63 Mn
Dec 31, 2023 31.02 Mn
Sep 30, 2023 32.59 Mn
Jun 30, 2023 34.53 Mn
Mar 31, 2023 37.87 Mn
Dec 31, 2022 48.79 Mn
Sep 30, 2022 53.11 Mn
Jun 30, 2022 58.03 Mn
Mar 31, 2022 67.42 Mn
Dec 31, 2021 84.09 Mn
Sep 30, 2021 91.72 Mn
Jun 30, 2021 99.92 Mn